Diacerein is a slow-acting anthraquinone derivative functioning as an interleukin-1 beta inhibitor, commonly used in the management of osteoarthritis. To ensure pharmaceutical quality and regulatory compliance,… Read more
















Diacerein is a slow-acting anthraquinone derivative functioning as an interleukin-1 beta inhibitor, commonly used in the management of osteoarthritis. To ensure pharmaceutical quality and regulatory compliance, rigorous analytical assessment is necessary. This category provides comprehensive reference standards, including pharmacopeial and non-pharmacopeial impurities, degradation products, and metabolites associated with this compound. Stable isotope labelled compounds, such as deuterium and 13C-labelled analogs, are also provided, serving as critical internal standards for precise quantification in mass spectrometry-based bioanalytical assays. These materials are essential for impurity profiling, method validation, and forced degradation studies, enabling laboratories to accurately identify and quantify related substances. By supporting routine quality control and stability testing, these well-characterized reference materials assist in the rigorous analytical evaluation of this therapeutic agent throughout its lifecycle.